These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 35989043)
41. Evaluation of texture analysis for the differential diagnosis of focal nodular hyperplasia from hepatocellular adenoma on contrast-enhanced CT images. Cannella R; Borhani AA; Minervini MI; Tsung A; Furlan A Abdom Radiol (NY); 2019 Apr; 44(4):1323-1330. PubMed ID: 30267107 [TBL] [Abstract][Full Text] [Related]
42. The use of 18F-fluoromethylcholine PET/CT in differentiating focal nodular hyperplasia from hepatocellular adenoma: a prospective study of diagnostic accuracy. Bieze M; Bennink RJ; El-Massoudi Y; Phoa SS; Verheij J; Beuers U; van Gulik TM Nucl Med Commun; 2013 Feb; 34(2):146-54. PubMed ID: 23154640 [TBL] [Abstract][Full Text] [Related]
43. Benign nodules in post-Fontan livers can show imaging features considered diagnostic for hepatocellular carcinoma. Wells ML; Hough DM; Fidler JL; Kamath PS; Poterucha JT; Venkatesh SK Abdom Radiol (NY); 2017 Nov; 42(11):2623-2631. PubMed ID: 28785785 [TBL] [Abstract][Full Text] [Related]
44. Inflammatory Hepatocellular Adenoma Mimicking Focal Nodular Hyperplasia That Grew during Pregnancy and Changed Its Appearance on Magnetic Resonance Imaging after Delivery. Hasuike S; Nagata K; Sasaki H; Hirata T; Suzuki S; Komaki Y; Ozono Y; Nakamura K; Miike T; Iwakiri H; Sueta M; Yamamoto S; Maekawa K; Kawakami H Intern Med; 2023 Nov; 62(21):3143-3149. PubMed ID: 37032077 [TBL] [Abstract][Full Text] [Related]
45. ACG Clinical Guideline: Focal Liver Lesions. Frenette C; Mendiratta-Lala M; Salgia R; Wong RJ; Sauer BG; Pillai A Am J Gastroenterol; 2024 Jul; 119(7):1235-1271. PubMed ID: 38958301 [TBL] [Abstract][Full Text] [Related]
46. Differentiation of focal nodular hyperplasia and hepatocellular adenoma using qualitative and quantitative imaging features and classification and regression tree analysis. Alamri TM; Cerny M; Al Shaikh M; Billiard JS; Olivié D; Chagnon M; Tang A Abdom Radiol (NY); 2023 Mar; 48(3):874-885. PubMed ID: 36528729 [TBL] [Abstract][Full Text] [Related]
47. Differentiation Between Hepatocellular Carcinoma Showing Hyperintensity on the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI and Focal Nodular Hyperplasia by CT and MRI. Kitao A; Matsui O; Yoneda N; Kita R; Kozaka K; Kobayashi S; Gabata T AJR Am J Roentgenol; 2018 Aug; 211(2):347-357. PubMed ID: 29708786 [TBL] [Abstract][Full Text] [Related]
49. Differentiation of hepatocellular carcinoma from its various mimickers in liver magnetic resonance imaging: What are the tips when using hepatocyte-specific agents? Park YS; Lee CH; Kim JW; Shin S; Park CM World J Gastroenterol; 2016 Jan; 22(1):284-99. PubMed ID: 26755877 [TBL] [Abstract][Full Text] [Related]
50. Growth of hepatocellular adenoma during pregnancy: A prospective study. Gaspersz MP; Klompenhouwer AJ; Broker MEE; Thomeer MGJ; van Aalten SM; Steegers E; Terkivatan T; de Koning H; de Man RA; Ijzermans JNM J Hepatol; 2020 Jan; 72(1):119-124. PubMed ID: 31550458 [TBL] [Abstract][Full Text] [Related]
51. Focal liver lesions in cirrhosis: value of contrast-enhanced ultrasonography compared with Doppler ultrasound and alpha-fetoprotein levels. D'Onofrio M; Faccioli N; Zamboni G; Malagò R; Caffarri S; Fattovich G; Mucelli RP Radiol Med; 2008 Oct; 113(7):978-91. PubMed ID: 18779929 [TBL] [Abstract][Full Text] [Related]
52. Differentiation of focal nodular hyperplasia from hepatocellular adenomas with low-mechanical-index contrast-enhanced sonography (CEUS): effect of size on diagnostic confidence. Roche V; Pigneur F; Tselikas L; Roux M; Baranes L; Djabbari M; Costentin C; Calderaro J; Laurent A; Rahmouni A; Luciani A Eur Radiol; 2015 Jan; 25(1):186-95. PubMed ID: 25120205 [TBL] [Abstract][Full Text] [Related]
54. Value of discrepancy of the central scar-like structure between dynamic CT and gadoxetate disodium-enhanced MRI in differentiation of focal nodular hyperplasia and hepatocellular adenoma. Park HJ; Byun JH; Kang JH; Kang HJ; Yu E; Lee SJ; Kim SY; Won HJ; Shin YM; Kim PN Eur J Radiol; 2021 Jun; 139():109730. PubMed ID: 33930719 [TBL] [Abstract][Full Text] [Related]
55. Diagnostic accuracy of MRI in differentiating hepatocellular adenoma from focal nodular hyperplasia: prospective study of the additional value of gadoxetate disodium. Bieze M; van den Esschert JW; Nio CY; Verheij J; Reitsma JB; Terpstra V; van Gulik TM; Phoa SS AJR Am J Roentgenol; 2012 Jul; 199(1):26-34. PubMed ID: 22733890 [TBL] [Abstract][Full Text] [Related]
56. Association Between Gadoxetic Acid-Enhanced Magnetic Resonance Imaging, Organic Anion Transporters, and Farnesoid X Receptor in Benign Focal Liver Lesions. van Rosmalen BV; Visentin M; Furumaya A; van Delden OM; Kazemier G; van Gulik TM; Verheij J; Stieger B Drug Metab Dispos; 2024 Jan; 52(2):118-125. PubMed ID: 38050024 [TBL] [Abstract][Full Text] [Related]
57. Application of superb microvascular imaging in focal liver lesions. He MN; Lv K; Jiang YX; Jiang TA World J Gastroenterol; 2017 Nov; 23(43):7765-7775. PubMed ID: 29209117 [TBL] [Abstract][Full Text] [Related]
58. [Contrast-enhanced ultrasound in differential diagnosis of focal liver lesions]. Katrich AN; Porkhanov VA Khirurgiia (Mosk); 2019; (6):49-59. PubMed ID: 31317941 [TBL] [Abstract][Full Text] [Related]
60. To assess the quantitative features of focal liver lesions in gadoxetic acid enhanced MRI and to determine whether these features can accurately differentiate benign form malignant lesions. Rybczynska DN; Markiet KE; Pienkowska JM; Szurowska E; Frydrychowski A Eur J Radiol; 2024 Feb; 171():111288. PubMed ID: 38194844 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]